300 results on '"Östergren, Jan"'
Search Results
2. Significant changes in emergency department length of stay and case mix over eight years at a large Swedish University Hospital
3. Changes in 24-h ambulatory blood pressure following restoration of sinus rhythm in patients with atrial fibrillation
4. Physicians’ and nurses’ perceptions of patient safety risks in the emergency department
5. Changes in cardiac output, rhythm regularity, and symptom severity after electrical cardioversion of atrial fibrillation.
6. Reasons for interrupting colleagues during emergency department work – A qualitative study
7. Factors influencing clinicians' perceptions of interruptions as disturbing or non-disturbing: A qualitative study
8. Contributing factors to errors in Swedish emergency departments
9. Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program
10. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
11. Diastolic Dysfunction in Heart Failure With Preserved Systolic Function: Need for Objective Evidence: Results From the CHARM Echocardiographic Substudy–CHARMES
12. Renin–angiotensin-system blockade in the prevention of diabetes
13. Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial
14. Interruptions in emergency department work: an observational and interview study
15. Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
16. Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program
17. Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme
18. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)
19. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
20. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
21. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme
22. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
23. The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure
24. Myocardial ischaemia in patients with peripheral arterial disease
25. †Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
26. Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial
27. Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme
28. Predictors of mortality and morbidity in patients with chronic heart failure
29. Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure
30. Plasma NT-proBNP concentration is related to ambulatory pulse pressure in peripheral arterial disease
31. Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource : Mixed Methods Study
32. Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease
33. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme
34. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
35. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
36. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial
37. Does individual learning styles influence the choice to use a web-based ECG learning programme in a blended learning setting?
38. Associations Between Crowding and Ten-Day Mortality Among Patients Allocated Lower Triage Acuity Levels Without Need of Acute Hospital Care on Departure From the Emergency Department
39. Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study
40. Systolic blood pressure increases in patients with atrial fibrillation regaining sinus rhythm after electrical cardioversion
41. Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study (Preprint)
42. Changes in 24-h ambulatory blood pressure following restoration of sinus rhythm in patients with atrial fibrillation.
43. Evaluation of a web-based ECG-interpretation programme for undergraduate medical students
44. High beat-to-beat blood pressure variability in atrial fibrillation compared to sinus rhythm
45. Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design
46. Dry Point
47. Contemporary
48. Indian Summer I
49. Microvascular Measurements in Patients with Arteriosclerosis
50. Capillary Flow Measurements in Human Skin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.